logo
D-Wave Quantum (QBTS) Showcases Revenue Growth, Record Cash, and Advantage2 Boost

D-Wave Quantum (QBTS) Showcases Revenue Growth, Record Cash, and Advantage2 Boost

D-Wave Quantum (QBTS) is one of the more promising quantum computing stocks on Wall Street. Over the past year, it has made major technology gains, built a stronger cash position, and seen its share price climb over 1800%. Last Thursday, the company reported its second-quarter results for 2025 with a mix of strong growth and ongoing challenges. The stock closed at $16.90 on August 8, down 1.57% for the day, and ticked slightly higher after hours. Year-to-date, the stock has gained 101%, helped by steady progress in its technology and customer reach.
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Quarter's Highlights & Lowlights
In the quarter, revenue rose 42% from last year to $3.1 million. Bookings climbed 92% to $1.3 million. The company credited this growth to the launch of its Advantage2 quantum computer. This system delivered a real-world result in materials simulation and improved on earlier models with double coherence time, a 40% increase in energy scale, and higher qubit connectivity.
D-Wave also reported a rise in its customer base. New and renewed agreements came from E.ON (FRA:EOAN), GE Vernova (GEV), Nikon Corporation, and the University of Oxford. The company also formed a strategic link with Yonsei University and Incheon Metropolitan City in South Korea. Customer retention stayed above 90%, with users spanning both corporate and government sectors.
At the same time, the company's net loss widened to $167.3 million from $17.8 million a year ago. This was mainly due to $142 million in noncash charges from warrant liability remeasurement. While second-quarter bookings grew strongly, bookings for the first half of the year fell 13% compared with the same period in 2024, as large enterprise deals took longer to close.
One clear strength is D-Wave's balance sheet. The company's cash position reached $819.3 million, supported by $500 million in equity raised during the quarter. Management said this will be used for research and development and possible acquisitions.
Top Analyst Raises His Price Target on QBTS
On the Street, analysts remain optimistic. In the past three months, 11 analysts rated the stock a Buy, with no Holds or Sells. The average price target is $22.18, about 31% above the last close. The highest target is $30, and the lowest is $20. Piper Sandler's top analyst, Harsh Kumar, raised his target from $13 to $22 after the earnings release, pointing to traction from Advantage2 and new business areas. Rosenblatt Securities' Kevin Garrigan has the highest target at $30, expecting a gain of over 77%.
TipRanks' AI Analyst rates the stock at 63 out of 100, which is Neutral. The model cites the company's leadership in applied quantum computing, its partnerships, and strong cash position as positives. It also flags the steep losses, slower booking pace in the first half, and valuation as negatives.
What's Next?
D-Wave plans to expand Advantage2 adoption through its Leap cloud service. It is also working on a gate-model quantum system aimed at problems in chemistry and fluid dynamics, areas that current annealing systems cannot solve. The company's roadmap includes more enterprise and government engagements and potential international expansion.
The next few quarters will show whether growing interest in quantum technology can translate into faster revenue growth and improved financial results.
Is QBTS a Good Stock to Buy?
The sentiment on the Street is on the bullish side, with D-Wave boasting a Strong Buy consensus rating. The average price target for QBTS stock is $22.18, implying a 31.24% upside for the current price.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Global High-Throughput Screening Market to Surpass USD 50.2 Billion by 2029
Global High-Throughput Screening Market to Surpass USD 50.2 Billion by 2029

Yahoo

time9 minutes ago

  • Yahoo

Global High-Throughput Screening Market to Surpass USD 50.2 Billion by 2029

Delray Beach, FL, Aug. 12, 2025 (GLOBE NEWSWIRE) -- North America Leads Today, Asia Pacific to Record Fastest GrowthThe global high throughput screening market, valued at US$25.7 billion in 2023, stood at US$28.8 billion in 2024 and is projected to advance at a resilient CAGR of 11.8% from 2024 to 2029, culminating in a forecasted valuation of US$50.2 billion by the end of the period. This growth is propelled by surging R&D investments in drug discovery, strategic government funding, and the increasing adoption of automation in life sciences research. Download PDF Brochure: What Is Driving the Market Now?HTS adoption is accelerating due to innovations in automation, miniaturization, and high-content screening, which significantly reduce discovery timelines and enhance precision in identifying therapeutic candidates. Grants such as the USD 7.8 million awarded to the University of Pittsburgh for advanced drug discovery systems underscore growing institutional and government commitment to high-impact research. Why Does This Matter for Global Pharma and Biotech Leaders?The market represents a critical enabler for competitive advantage in lead discovery, target validation, compound profiling, and hit identification—processes essential for pipeline acceleration. While high instrument costs remain a barrier, particularly for automated liquid handling and high-resolution imaging systems, emerging markets such as China and India offer lucrative opportunities with strong government support and an expanding pharmaceutical manufacturing base. Who Are the Key Stakeholders?The HTS ecosystem spans pharmaceutical giants, biotechnology innovators, academic institutions, and technology providers, all collaborating to enhance assay development and manage the rising complexity of biological data. The consumables segment—driven by recurring purchases of reagents and kits—dominates the market, ensuring steady demand as HTS workflows expand globally. Request Sample Pages: Where Is Growth Coming From? North America currently leads, fueled by advanced HTS infrastructure, robust funding for life science research, and a thriving biotech sector. Asia Pacific is projected to be the fastest-growing region, supported by a diverse patient base, strong pharmaceutical capabilities, and favorable regulatory environments. How Are Market Leaders Responding? Thermo Fisher Scientific Inc. maintains global leadership through an extensive portfolio of automated systems, screening instruments, and consumables, underpinned by 3% annual R&D investment and strategic alliances. Agilent Technologies, Inc. offers highly customizable workflows via BioTek detection instruments and Gen6 software, strengthened by acquisitions such as e-MSion (US) to enhance mass spectrometry capabilities. Merck KGaA delivers a diverse portfolio of reagents, instruments, software, and services, leveraging global reach and deep customer relationships across pharma, academia, and government sectors. Market OutlookAs automation, AI-driven data analysis, and advanced assay development converge, HTS will remain at the forefront of pharmaceutical innovation. Decision-makers who strategically invest in HTS capabilities today will be best positioned to accelerate therapeutic pipelines, capture market share, and deliver faster, more targeted treatments to market. For more information, Inquire Now Discover Connected Healthcare Market Opportunities:Drug Screening MarketCarrier Screening MarketCell based Assays MarketLabel Free Detection MarketLife Science Instrumentation Market Get access to the latest updates on High-Throughput Screening Companies and High-Throughput Screening Market Size CONTACT: About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Rohan Salgarkar MarketsandMarkets™ INC. 1615 South Congress Ave. Suite 103, Delray Beach, FL 33445, USA: +1-888-600-6441 Email: sales@ Visit Our Website: while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

Intel CEO meets with Trump, Cardinal Health to acquire Solaris: Morning Buzz
Intel CEO meets with Trump, Cardinal Health to acquire Solaris: Morning Buzz

Business Insider

time3 hours ago

  • Business Insider

Intel CEO meets with Trump, Cardinal Health to acquire Solaris: Morning Buzz

The major averages were broadly higher near noon after the headline consumer price index rose 0.2% in July and the core increased 0.3%, exactly as forecast. The news reassured investors who were concerned about Trump's tariff policies potentially spiking prices in the U.S. economy. The tame inflation report might give the Federal Reserve the green light to cut interest rates next month, traders appear to be surmising. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Looking to commodities, gold prices were fractionally lower, falling to below $3,400 for the first time in weeks. Meanwhile, oil prices continue their decline ahead of Tuesday's API crude numbers. morning Fly By on YouTube. 1. STOCK NEWS: Intel (INTC) said CEO Lip-Bu Tan had a 'candid' and 'constructive' discussion with President Trump, with the president calling the meeting 'interesting' Meanwhile, Trump said that Goldman Sachs (GS) CEO David Solomon should 'focus on being a DJ' instead of running a bank, tying the criticism to Goldman's previous statement's about tariffs Cardinal Health (CAH) provided a 'beat and raise' report for Q4 and agreed to acquire Solaris Health for $1.9B in cash China is urging companies not tot use Nvidia's (NVDA) H20 chips, Bloomberg reports Sinclair (SBGI) has launched a strategic review for its broadcast business 2. WALL STREET CALLS: Starbucks (SBUX) upgraded at Baird, here's why Piper upgraded Chipotle (CMG) to Overweight after 31% selloff Shopify (SHOP) downgraded to Neutral from Accumulate at Phillip Securities Palo Alto Networks (PANW) upgraded to Overweight from Neutral at Piper Sandler PubMatic downgraded to Neutral at B. Riley and Hold at Lake Street after softer than expected Q3 outlook 3. AROUND THE WEB: Perplexity has offered $34.5B to acquire Google's (GOOGL) Chrome browser, The Wall Street Journal reports Gildan Activewear (GIL) is weighing a cash and stock offer for Hanesbrands (HBI) that would value the company at about $6 a share, Bloomberg reports Citigroup (C) Chief Executive Officer Jane Fraser is in Mexico City for talks with President Claudia Sheinbaum that include the potential public listing of her bank's retail unit Banamex, Bloomberg says Amdocs (DOX) is set to lay off 'hundreds' of employees, including many in Israel, Globes reports General Motors (GM) seeks to hire back some former employees of its Cruise autonomous vehicle business in a renewed push to develop self-driving cars, Bloomberg reports 4. MOVERS: WideOpenWest (WOW) increases after announcing it will be taken private by DigitalBridge in a $1.5B deal Green Dot (GDOT) higher after reporting Q2 results and raised its guidance for FY25 Gevo (GEVO) and 3D Systems (DDD) gains after reporting quarterly results Fluence Energy (FLNC) lower after reporting Q3 results and backing its guidance for FY25 BigBear. ai (BBAI) and Microvast (MVST) fall after reporting quarterly results 5. EARNINGS/GUIDANCE: On Holding (ONON) reported Q2 results and raised its guidance for FY25 Celanese (CE) reported Q2 results, with EPS and revenue beating consensus Smithfield Foods (SFD) reported Q2 results, with CEO Shane Smith commenting, 'Our strong second quarter results demonstrate the agility and resilience of our business' Venture Global (VG) reported Q2 results and backed its guidance for FY25, with CEO Mike Sabel commenting, 'We are pleased to announce another strong quarter' Circle Internet (CRCL) reported Q2 results, with revenue beating consensus INDEXES: Near midday, the Dow was up/down xxx, or xxx%, to xxx, the Nasdaq was up/down xxx, or xxx%, to xxx, and the S&P 500 was up/down xxx, or xxx%, to xxx.

Morning News Wrap-Up: Tuesday's Biggest Stock Market Stories!
Morning News Wrap-Up: Tuesday's Biggest Stock Market Stories!

Business Insider

time3 hours ago

  • Business Insider

Morning News Wrap-Up: Tuesday's Biggest Stock Market Stories!

Investors on the lookout for all of the hottest stock market stories are in the right place. TipRanks is home to a roundup of all the biggest stock market news and headlines traders need to know about on Tuesday! Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. WideOpenWest (WOW) stock rallied today after it announced a $1.5 billion deal that would take it private. Archer Aviation (ACHR) stock was down after the company failed to impress investors with its Q2 earnings report. Oklo (OKLO) stock dipped after the company missed estimates in its most recent earnings report. ProPhase Labs (PRPH) stock rocketed higher after the company was granted a patent for its biomarker-based systems and methods. Myomo (MYO) stock plummeted after the company slashed its revenue guidance despite a Q2 beat. 180 Life Sciences (ATNF) stock soared after the company announced its purchase of $349 million worth of Ethereum (ETH). The Dow Jones Industrial Average (DJIA) was up today alongside the latest inflation data from the Bureau of Labor Statistics. AST SpaceMobile (ASTS) stock took off after it revealed a fully funded satellite deployment plan to rival SpaceX. BigBear. ai Holdings (BBAI) stock was down after analysts weighed in on the shares following the company's latest earnings report. Kodak (KODK) stock plummeted after the company provided a going-concern warning in its Q2 earnings report. Advanced Micro Devices (AMD) CEO Lisa Su said she 'Absolutely, 100 percent' supports bringing chip manufacturing back to the U.S. Berkshire Hathaway (BRK.B) is expected to reveal a new mystery stock later this week. SoundHound AI (SOUN) stock rallied as more analysts updated coverage alongside a bullish wave. Roblox (RBLX) stock gained even as the company faced increased pressure over predator allegations.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store